Articles

Poll

Podcasts

Slideshows

Videos

Nephrology

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

The 2025 KDIGO guidelines guide mechanism-driven therapy in IgA nephropathy, highlighting targeted interventions across the 4-hit disease cascade.

KDIGO 2025 Guides Mechanism-Driven Therapy in IgA Nephropathy, With Luis Russo, MD, MS

2025 KDIGO guidelines reshape IgA nephropathy care with earlier biopsy, tighter proteinuria targets, and personalized treatment strategies.


How the 2025 KDIGO Guidelines Are Personalizing IgA Nephropathy Care, With Gerald Appel, MD

Andrew Vissing shares his clinical perspective and strategies to mitigate gaps in care and management for young adults with glomerular disease.


Implementing Age-Specific Care For Young Adults With Glomerular Disease With Andrew Vissing, MD

New CureGN findings and an interview with Andrew Vissing, MD, highlight distinct glomerular disease outcomes in adolescents and young adults compared with pediatric and adult patients


Unmet Needs of Glomerular Disease in Young Adults, Adolescents With Andrew Vissing, MD

Quarter 4 2025 showed robust advancements in the nephrology field, including FDA news, trial updates, and featured content. 

Q4 2025 Recap: Nephrology News and Updates

An age-based observational study in glomerular disease suggests different rates of disease progression and remission in young adults compared to adult and pediatric patients. 


Adolescents, Young Adults With Glomerular Disease May Require Distinct Care

The FDA grants priority review of Vera Therapeutics’s Biologics License Application for the B-cell modulating, atacicept, in IgAN. 


FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

IgA nephropathy advanced in 2025 with FDA approvals, positive phase 3 trials, and growing disease-modifying therapies


IgA Nephropathy in 2025: Year in Review

In 2025, FDA approvals, pivotal trials, and emerging therapies shifted nephrology care toward precision and mechanism-driven kidney medicine.


Nephrology in 2025: Year in Review

Findings from a retrospective observational cohort study indicate podometrics may inform a less invasive treatment approach in IgA nephropathy (IgAN).


Podometrics Could Guide IgAN Treatment While Reducing Invasiveness

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.